Author profile
Hugh D. Tildesley, MD
Background Diabetic nephropathy is currently the leading cause of end-stage renal disease in the western world. This makes being able to determine when renal function is on the decline of vital importance and... Read More
Background Diabetes mellitus is a chronic metabolic disease affecting more than 2 million Canadians, and its prevalence is expected to rise to 3 million by the year 2010.[1] Approximately 85% to 90% of... Read More
Background According to a report issued by Health Canada in 2002, 4.8% of Canadians, 20 years of age and older, had type 2 diabetes mellitus in 1998–1999.[1] In British Columbia, the prevalence rate is... Read More
Many BC physicians have lost confidence in the province’s drug review process through the Therapeutics Initiative. Here are some solutions. There is a growing concern in Canada and particularly in British Columbia... Read More
Advances in the treatment of type 1 diabetes (T1D) in the past decade have occurred in the areas of treatments and treatment philosophy. The push for new insulin analogs such as glargine, aspart, and lispro came in part... Read More
Background Diabetes mellitus is an important cause of death, illness, and disability across Canada. It affects approximately 5% of adults, which means more than 1 million Canadians.[1,2] Having diabetes... Read More